MENU
Home
Add Document
Sign In
Create An Account
PDF Reader
Full Text
Downloaded by: Dahlgree Med. Library, Goergetown Univ. 198.143.37.66 - 8/18/2015 2:00:17 PM
Downloaded by: Dahlgree Med. Library, Goergetown Univ. 198.143.37.66 - 8/18/2015 2:00:17 PM
Downloaded by: Dahlgree Med. Library, Goergetown Univ. 198.143.37.66 - 8/18/2015 2:00:17 PM
Downloaded by: Dahlgree Med. Library, Goergetown Univ. 198.143.37.66 - 8/18/2015 2:00:17 PM
Downloaded by: Dahlgree Med. Library, Goergetown Univ. 198.143.37.66 - 8/18/2015 2:00:17 PM
Downloaded by: Dahlgree Med. Library, Goergetown Univ. 198.143.37.66 - 8/18/2015 2:00:17 PM
Suggest Documents
vincristine therapy in small cell lung cancer.
Hydrazine sulfate in nonsmall-cell lung cancer.
etoposide in small cell lung cancer.
Oxaliplatin-Based Doublets Versus Cisplatin or Carboplatin-Based Doublets in the First-Line Treatment of Advanced Nonsmall Cell Lung Cancer.
Serum response heterogeneity among nonsmall cell lung cancer cell lines.
Pemetrexed-associated Ischemic Colitis in Nonsmall Cell Lung Cancer.
Therapeutic options targeting angiogenesis in nonsmall cell lung cancer.
MicroRNA-224 promotes tumor progression in nonsmall cell lung cancer.
The possibility of traditional chinese medicine as maintenance therapy for advanced nonsmall cell lung cancer.
Delayed esophageal perforation from stereotactic body radiation therapy for locally recurrent central nonsmall cell lung cancer.
Effectiveness of maintenance treatments for nonsmall cell lung cancer.
Radiofrequency ablation for early-stage nonsmall cell lung cancer.
Refining the treatment of advanced nonsmall cell lung cancer.
Evaluation of Three Small Molecular Drugs for Targeted Therapy to Treat Nonsmall Cell Lung Cancer.
Therapeutic management of ALK+ nonsmall cell lung cancer patients.
VMAT Technique for Nonsmall Cell Lung Cancer.
Irinotecan and Carboplatin (IC) Regimen for Small-Cell Lung Cancer and Non-Small-Cell Lung Cancer.
Clinical and prognostic significance of Merkel cell polyomavirus in nonsmall cell lung cancer.
Noncoding RNA small nucleolar RNA host gene 1 promote cell proliferation in nonsmall cell lung cancer.
DNA methylation of DKK3 modulates docetaxel chemoresistance in human nonsmall cell lung cancer cell.
Blocking the PI3K pathway enhances the efficacy of ALK-targeted therapy in EML4-ALK-positive nonsmall-cell lung cancer.
Cisplatin-carboplatin therapy in extensive non-small cell lung cancer: a Cancer and Leukemia Group B study.
Tumor heterogeneity and resistance to EGFR-targeted therapy in advanced nonsmall cell lung cancer: challenges and perspectives.
paclitaxel in patients with advanced nonsquamous nonsmall-cell lung cancer (NSCLC): Asian subgroup analysis.
carboplatin therapy in non-small cell lung cancer.
Based on in vitro experiments suggesting cytotoxic activity of at least a supra-additive effect, a phase I clinical study of carboplatin/cisplatin seq...
2MB Sizes
0 Downloads
0 Views
Download PDF
Recommend Documents
vincristine therapy in small cell lung cancer.
Hydrazine sulfate in nonsmall-cell lung cancer.
etoposide in small cell lung cancer.
Oxaliplatin-Based Doublets Versus Cisplatin or Carboplatin-Based Doublets in the First-Line Treatment of Advanced Nonsmall Cell Lung Cancer.
Serum response heterogeneity among nonsmall cell lung cancer cell lines.
Pemetrexed-associated Ischemic Colitis in Nonsmall Cell Lung Cancer.
Therapeutic options targeting angiogenesis in nonsmall cell lung cancer.
MicroRNA-224 promotes tumor progression in nonsmall cell lung cancer.
The possibility of traditional chinese medicine as maintenance therapy for advanced nonsmall cell lung cancer.
Delayed esophageal perforation from stereotactic body radiation therapy for locally recurrent central nonsmall cell lung cancer.
×
Sign In
Login with Facebook
Don't have an account?
Forgot Password?
×
Sign Up
By clicking register, I agree to your terms